Terms used to describe and define activities undertaken as a result of the medication review process: Do they require standardisation? A systematic review.
Mohammed S AlharthiDavid WrightSion ScottJeanette BlacklockPublished in: International journal of clinical pharmacy (2022)
The literature reports a variety of overlapping, ambiguous and undefined MR terms. As a result, comparing process evaluations from MR interventions may be difficult. A standardised taxonomy to describe, define and report MR activities is required.